AOD-9604 raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
Reviewed 2026-05-25. Anything still debated is marked as such rather than presented as settled.
AOD-9604 has been investigated mainly in the context of body fat and metabolic endpoints. Some early animal and small human studies reported changes in fat mass or lipid markers, but findings were not uniform. Larger, well-controlled trials that would establish efficacy are lacking in the public literature. As a result, claims about weight loss or metabolic benefit remain investigational rather than established. The distinction between a research finding and a proven clinical outcome is central to discussing this peptide.
Regulatory bodies have taken different approaches to AOD-9604. It is not approved as a prescription medicine by major agencies such as the U.S. Food and Drug Administration or the European Medicines Agency. In sport, the World Anti-Doping Agency prohibits peptide hormones, growth factors, and related substances, and AOD-9604 has been treated as a prohibited substance. These regulatory decisions reflect concerns about safety, efficacy, and potential misuse rather than proof of benefit.
Detection of AOD-9604 in biological samples relies on analytical techniques capable of distinguishing a small synthetic peptide from related endogenous sequences. Liquid chromatography coupled with tandem mass spectrometry is commonly used for confirmatory analysis. Sample preparation may involve immunoaffinity enrichment or solid-phase extraction to concentrate the peptide. Because the molecule is small and may be present at low concentrations, assay sensitivity and specificity are ongoing analytical challenges. Laboratories also validate methods against reference materials when available.
Regulatory interest in AOD-9604 increased after high-profile anti-doping cases involving peptide products. In some cases, the substance was supplied under alternative names or in compounded preparations, complicating traceability. Sports tribunals and anti-doping panels have discussed whether the peptide was explicitly banned at the time of use, leading to clarifications by the World Anti-Doping Agency. For consumers and researchers, the legal status can vary by jurisdiction, and products marketed as research chemicals may lack independent quality verification.
AOD-9604 is listed as a prohibited substance in sport by the World Anti-Doping Agency. It falls under the peptide hormones, growth factors, related substances, and mimetics class on the prohibited list. Anti-doping organizations treat its presence in an athlete's sample as an adverse finding unless a therapeutic use exemption applies. The prohibition reflects concerns about performance enhancement in competitive settings and the difficulty of distinguishing exogenous peptide use from endogenous hormone fragments.
| Property | Value | Notes |
|---|---|---|
| Regulatory status | Not approved as a medicine | Major agencies have not authorized it for therapeutic use. |
| Anti-doping status | Prohibited in sport | Listed among peptide hormones and related substances. |
| Primary research area | Metabolic and body-composition effects | Studies often examine fat mass or lipid markers. |
| Human evidence | Limited and mixed | Public data do not establish clinical efficacy. |
| Analytical detection | LC-MS and immunoassays | Methods vary in sensitivity and validation. |
AOD-9604 is a synthetic peptide that corresponds to a short section of human growth hormone. It is commonly identified as hGH fragment 176-191 because its sequence matches residues at the C-terminal end of the hormone. The molecule contains sixteen amino acids and is made by solid-phase peptide synthesis. Researchers study it for metabolic effects rather than for the growth-promoting actions associated with full human growth hormone. Its small size distinguishes it from the complete 191-amino-acid hormone.
Several names appear in scientific and commercial settings. AOD9604 and AOD-9604 are development codes used interchangeably, while hGH fragment 176-191 describes the same region. The peptide includes a disulfide bond between two cysteine residues, which helps shape its three-dimensional structure. Different suppliers may provide acetate or other salt forms, and purity can vary. These differences matter because analytical tests and biological assays can respond to the specific form being studied.
Early interest in AOD-9604 centered on whether a fragment of human growth hormone could influence fat metabolism without the broader effects of the full hormone. Cell and animal studies reported changes in fat storage and breakdown. Human trials followed, but the results were not strong enough to secure regulatory approval. The compound remains available for laboratory research, and its clinical potential is still described as uncertain. Studies continue to examine its activity and safety profile.
Proposed mechanisms for AOD-9604 focus on fat cells. Laboratory studies suggest the peptide can increase lipolysis, the breakdown of stored fat, and reduce lipogenesis, the formation of new fat. Unlike full human growth hormone, it does not appear to stimulate substantial IGF-1 production in the studies reported so far. Some evidence points to beta-adrenergic signaling, but the precise receptor targets and downstream pathways remain unresolved. The fragment is not thought to act through the classical growth hormone receptor.
Clinical development of AOD-9604 included trials in people with obesity. Reports from early-phase and mid-phase studies described modest or inconsistent changes in body weight. A phase IIb program did not meet its primary endpoint, and the compound was not approved for medical use. Differences in formulation, delivery route, and participant characteristics may explain some of the variation. Later investigations explored whether the peptide might have effects in other tissues, including cartilage.
Regulatory treatment of AOD-9604 is shaped by its classification as a peptide hormone. The World Anti-Doping Agency lists it as a prohibited substance, and many national anti-doping organizations adopt that list. It does not hold approval as a prescription medicine in the United States, the European Union, or other major markets. Products sold online are frequently labeled for research use only and may not undergo independent quality testing. Import and possession rules differ by country, so legal status depends on local law.
AOD-9604 is a synthetic peptide whose sequence is modeled on the C-terminal region of human growth hormone. Published descriptions commonly place it as a modified fragment corresponding to hGH amino acids 176–191, with a tyrosine residue added or retained at the N-terminus to support detection and handling. It is not intact growth hormone and lacks the full receptor-binding architecture of the parent protein. The molecule was developed as a research candidate for metabolic studies rather than as a replacement for growth hormone therapy. Its identity is defined by its amino acid sequence rather than by any single commercial preparation.
AOD-9604 drew attention in the 1990s and 2000s as a potential anti-obesity agent. Early work explored both injectable and oral routes, which is unusual for a peptide of this size. Animal studies reported changes in fat metabolism without the growth-promoting or insulin-like effects associated with full-length growth hormone. Subsequent human trials produced mixed or modest results, and the compound did not obtain regulatory approval for weight management in major markets. It remains known mainly through research literature, sports anti-doping listings, and non-approved supplement advertising.
AOD-9604 is typically supplied as a lyophilized white to off-white powder. In this form, it is relatively stable when kept cool, dry, and protected from light. Common storage recommendations place it at −20 °C or below for long-term retention. Reconstituted solutions are less stable and are often kept at 2–8 °C for short periods. Freeze-thaw cycles should be minimized because they can promote aggregation or loss of peptide content. Vials are usually sealed under inert gas to reduce oxidation.
Identity and purity are commonly checked with reversed-phase high-performance liquid chromatography and mass spectrometry. RP-HPLC separates the peptide from related impurities and can estimate purity by peak area. Mass spectrometry confirms molecular mass and helps detect sequence variants or truncations. Some laboratories use amino acid analysis or peptide mapping for additional characterization. No single method proves biological activity; these techniques establish chemical identity and purity only. They also require suitable reference standards for confident comparison.
Baeckeoffe, a potato stew from Alsace Beef bourguignon, a French dish of beef stewed in red burgundy wine Bigos, a traditional stew in Polish cuisine Birria, a traditional stew from Mexico Bo kho (Vietnamese: bò kho), a beef stew in rich seasonings, served with bread, noodle or plain rice from Vietnam Bollito misto, consisting of beef, veal, and pork simmered in an aromatic vegetable broth from Italy Booyah, an American meat stew Bosnian pot, a stew with beef or lamb which is a national dish in Bosnia and Herzegovina Bouillabaisse, a fish stew from Provence Brongkos, a spicy Javanese meat with beans stew from Indonesia, made of Pangium edule, coconut milk, and various spices Brunswick stew, from Virginia and the Carolinas Burgoo, a Kentuckian stew Brudet, fish stew from Dalmatia regions, known in Greece as bourdeto Caldeirada, a fish stew from Portugal Carbonade flamande (stoofvlees), a traditional Belgian beef and onion stew made with Belgian beer Cawl, a Welsh stew Chakapuli, a Georgian stew made with lamb chops, coriander and tarragon leaves, and white wine Chanakhi, a Georgian lamb stew with tomatoes, aubergines, potatoes, greens, and garlic Charquicán, a Chilean dish Chicken mull, whole chicken and seasonings Chicken paprikash, chicken stew with paprika Chili con carne, a meat and chili pepper stew originating in Texas Chilorio, a pork stew from Sinaloa, Mexico Cincinnati chili, developed by Macedonian immigrants from Greece immigrants in the Cincinnati area Cholent, a slow-cooked Jewish dish Chorba (also spelt "shorba"), a stew like soup dish found in various North African, Middle Eastern, Central Asian, South Asian, and European cuisines Cochinita pibil, an orange color pork stew from Yucatán Peninsula, Mexico Cocido, a traditional Spanish and Portuguese strew with many variants (madrileño, montañés, à portuguesa, etc.) Cotriade, a fish stew from Brittany Cream stew, a yōshoku Japanese white stew Crow stew, a sour cream-based stew made with crow meat, popular in the United States during the Great Depression Daal, the Indian legume stew that has many varieties, a staple food throughout Asia Dalma, a traditional dish of Odisha, India; contains pulses with vegetables Daube, a French stew made with cubed beef braised in wine, vegetables, garlic, and herbs Dinuguan, pork blood stew from the Philippines Eintopf, ('one pot') the German word for a stew: many different regional specialty recipes for Eintopf are known in Germany. For example, the Kassel area has a type called Lumben un Fleeh in the local dialect (Standard German: Lumpen und Flöhe – 'rags and fleas'), which is quite similar to Irish stew. There are thicker German stews such as Hasenpfeffer or Labskaus; these would not usually be considered an Eintopf, though the technical difference is minor (longer cooking times and fewer vegetables) Estofadong baboy, pork stew from the Philippines Ewedu, vegetable stew from Nigeria Fabada asturiana, an Asturian bean and meat stew Feijoada, Brazilian or Portuguese bean stew Fårikål, traditional Norwegian stew with lamb or mutton and white cabbage Főzelék, a thick Hungarian vegetable dish Gaisburger Marsch, a German dish of stewed beef served with Spätzle and potatoes Gheimeh, an Iranian stew with cubed lamb and yellow split peas Ghormeh sabzi, an Iranian stew with green herbs, dried limes, beans, and sheep meat Goulash, a Hungarian meat stew with paprika Gumbo, a Louisiana creole dish Hachee, a Dutch type of stew with wine or vinegar Haleem, an Indian-Pakistani lentil and beef stew Hasenpfeffer, a sour, marinated rabbit stew from Germany Hayashi rice, a Japanese dish of beef, onions and mushrooms in red wine and demi-glace sauce, served with rice Irish stew, made with lamb or mutton, potato, onion, and parsley Ishtu, a curry in Kerala, India made from chicken or mutton, potato, and coconut milk Istrian stew or yota, or jota, a dish popular in Croatian and Slovenian Istra and NE Italy I-tal stew, a Rastafarian vegan dish of mostly Caribbean root vegetables and spices Jjigae, a diverse range of Korean stews Kaldereta, a goat meat stew from the Philippines Kalops, a traditional Swedish beef stew, with onions and carrots, served with potatoes and pickled beets Kare-kare, stewed beef or oxtail and vegetables in peanut sauce from the Philippines Karelian hot pot, from the region of Karelia in eastern Finland Kharcho is a traditional Georgian soup containing beef, rice, cherry plum purée, and chopped walnuts Khash, a traditional Armenian/Azerbaijani dish of pig's or cow's feet Khoresht, a variety of Persian stews, often prepared with saffron Kokkinisto, Greek stew with red meat, in a tomato passata with shallots, cinnamon, and other spices Kuurdak, a type of stew from Central Asia Kuzhambu, (also called Pulusu or Saaru, depending on region) a range of stews from southern India based on tamarind broth and vegetables, meat or fish Lobscouse, a Norwegian stew with beef, potato, onion, and carrot Lancashire hotpot, an English stew Lecsó, a summertime favourite in Hungary, vegetable stew with bell pepper and tomato as main ingredients Linseneintopf ("lentil stew") Lobby, a stew from Staffordshire, England Locro, a stew (mainly in the Andes region) Machanka, a Belarus and Ukraine pork stew Matelote, a French fish stew made with freshwater fish, fish stock, and wine Mechado, a Philippine beef stew Moppelkotze Moqueca, a Brazilian stew with fish (or shrimp, crab, or other seafood) as its main ingredient Mućkalica, a Serbian stew Nihari, an Indian meat stew, usually made with goat, chicken, lamb and less commonly beef. It is made overnight and served for breakfast. Nikujaga, a Japanese beef and potato stew Oil down, national dish of Grenada, made of breadfruit, salted meat, chicken, dumplings, callaloo, coconut milk, and spices Olla podrida, a Spanish red bean stew Pašticada, a Croatian stew from the region of Dalmatia Peperonata, an Italian stew made with peppers Pepposo, a Tuscan beef stew Pescado blanco, a white fish stew from Pátzcuaro, Michoacán, Mexico Pichelsteiner a traditional German stew Pörkölt, a Hungarian meat stew resembling goulash, flavoured with paprika Potjiekos, a South African stew Pot-au-feu, a simple French beef stew Pozole, a Mexican stew or soup Puchero, a stew from Andalusia, Spain, also common in South America and the Philippines Ratatouille, a French vegetable stew Rendang, an Indonesian spicy beef stew Ragoût, a French stew Sāmbār, a lentil-based spiced vegetable stew, cooked with pigeon pea and tamarind broth in South Indian cuisine Sancocho, a stew from the Caribbean Scouse, a stew commonly eaten by sailors throughout Northern Europe, popular in seaports such as Liverpool Semur, a typical Indonesian stew with beef or chicken, potatoes, carrots, various spices, and kecap manis (sweet soy sauce) Stufato, an Italian stew Steckrübeneintopf (based on rutabaga) Slumgullion, a watery stew of meat and vegetables Tagine, a Moroccan stew, named after the conical pot in which it is traditionally cooked or served Tocană, a Romanian stew prepared with tomato, garlic, and sweet paprika Tharid, a traditional Arab stew of bread in broth Wat, an Ethiopian and Eritrean stew Waterzooi, a Belgian stew Yahni, a Greek (γιαχνί), Turkish, and Persian stew
During maximum intensity exercise, muscle glycogen can supply 40 mmol glucose/kg wet weight/minute, whereas blood glucose can supply 4 – 5 mmol. Due to its high supply rate and quick ATP synthesis, during high-intensity aerobic activity (such as brisk walking, jogging, or running), the higher the exercise intensity, the more the muscle cell produces ATP from muscle glycogen. This reliance on muscle glycogen is not only to provide the muscle with enough ATP during high-intensity exercise, but also to maintain blood glucose homeostasis (that is, to not become hypoglycaemic by the muscles needing to extract far more glucose from the blood than the liver can provide). A deficit of muscle glycogen leads to muscle fatigue known as "hitting the wall" or "the bonk" (see below under glycogen depletion).
== Mechanism == The reaction catalyzed by this enzyme proceeds via a ping-pong mechanism by using 2 equivalents of NAD(P)H to reduce one equivalent of the azo compound substrate (for example methyl red where Ar = p-dimethylaniline and Ar' = o-benzoic acid) into two equivalents of aniline product:
== ABC News report == An 11-segment series of reports in March 2012 from ABC News brought widespread public attention to and raised consumer concerns about the product. The product was described as "essentially scrap meat pieces compressed together and treated with an antibacterial agent". Lean finely textured beef (LFTB) was referred to as "an unappetizing example of industrialized food production". The product has been characterized as "unappetizing, but perhaps not more so than other things that are routinely part of hamburger" by Sarah Klein, an attorney for the food safety program at the Center for Science in the Public Interest. Nutritionist Andy Bellatti has referred to the product as "one of many symptoms of a broken food system". Food policy writer Tom Laskawy noted that ammonium hydroxide is only one of several chemicals routinely added to industrially produced meat in the United States. It was reported at that time that 70% of ground beef sold in US supermarkets contained the additive, and that the USDA considered it as meat. The USDA issued a statement that LFTB was safe and had been included in consumer products for some time, and its Under Secretary of Agriculture for Food Safety Elisabeth A. Hagen stated that "The process used to produce LFTB is safe and has been used for a very long time. And adding LFTB to ground beef does not make that ground beef any less safe to consume".
Sources: en.wikipedia.org
Although they lacked the managerial acumen and cultural cachet of the Grateful Dead and elected to remain in East Palo Alto, California, unlike the former group, which soon relocated to the Haight-Ashbury district of San Francisco, the New Delhi River Band were considered by late 1966 to be the house band of The Barn (one of the region's few viable concert venues outside of San Francisco) in Scotts Valley, California. The group continued to enjoy a cult following in Santa Clara and Santa Cruz Counties through the Summer of Love until their dissolution in early 1968. After a period of inactivity Nelson contributed to the Grateful Dead's Aoxomoxoa (1969) sessions and served as the caretaker of Big Brother and the Holding Company's rehearsal space while guitarist Peter Albin and drummer David Getz undertook a European tour with Country Joe & the Fish following the schismatic departure of Janis Joplin and Sam Andrew from the former band in December 1968. During this period Nelson and Garcia played intermittently in an early iteration of High Country, a traditional bluegrass ensemble formed by the remnants of the Peninsula folk scene. Nelson was set to serve as lead guitarist in the reconstituted lineup of Big Brother that coalesced later in 1969 and thus may have contributed to some of the recordings on Be a Brother (1970) during this transitional period.
Plastocyanin is one of the family of blue copper proteins that are involved in electron transfer reactions. The copper-binding site is described as distorted trigonal pyramidal. The trigonal plane of the pyramidal base is composed of two nitrogen atoms (N1 and N2) from separate histidines and a sulfur (S1) from a cysteine. Sulfur (S2) from an axial methionine forms the apex. The distortion occurs in the bond lengths between the copper and sulfur ligands. The Cu−S1 contact is shorter (207 pm) than Cu−S2 (282 pm). The elongated Cu−S2 bonding destabilizes the Cu(II) form and increases the redox potential of the protein. The blue color (597 nm peak absorption) is due to the Cu−S1 bond where S(pπ) to Cu(dx2−y2) charge transfer occurs. In the reduced form of plastocyanin, His-87 will become protonated with a pKa of 4.4. Protonation prevents it acting as a ligand and the copper site geometry becomes trigonal planar.
=== Towards type I === According to Carl Sagan, Type I should be reached around 2100. Physicist and futurist Michio Kaku has suggested that, if humans increase their energy consumption at an average rate of 3 percent per year, they could reach Type I status in 100–200 years, Type II status in a few thousand years, and Type III status in 100,000 to a million years. Physicist Freeman Dyson has calculated that Type I should be reached in about 200 years, while Richard Carrigan has estimated that the Earth is just four-tenths of the way to Type I on the Sagan scale. If Type I is reached soon (in the year 3000 for Richard Wilson), it would be accompanied by profound social upheavals, but also by a significant risk of self-destruction. According to Per Calissendorff, energy consumption cannot be the main parameter to explain the transition from one type to another. Civilizations must have the means to maintain their growth rate despite climatic conditions and major natural disasters, even on the cosmic scale. A civilization moving towards Type II must have mastered space travel, interplanetary communication, stellar engineering, and climate. It must also have developed a planetary communication system, such as the Internet. For Michio Kaku, the only serious threat to a Type II civilization would be the explosion of a nearby supernova, while no known cosmic catastrophe would be capable of wiping out a Type III civilization. According to Philip T. Metzger, humanity has reached Type I, but faces an energy challenge.
Sources: en.wikipedia.org
No. It is not approved as a therapeutic drug by major regulators. It is sold for research purposes in many settings, which is not the same as clinical approval.
It is classified among peptide hormones and related substances that are prohibited in sport. The ban reflects anti-doping rules rather than a judgment that the peptide is effective for performance enhancement.
Human studies are limited and have not produced consistent evidence of meaningful clinical benefit. Some early trials examined metabolic endpoints, but larger confirmatory trials are generally lacking.
Yes, the World Anti-Doping Agency classifies AOD-9604 as a prohibited peptide hormone and related substance. Its use by athletes is banned under the relevant anti-doping code.